Ventricular Arrhythmia Treatments

Latest Health Related News:
Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data On SLx-4090 At The 16th International Symposium On Drugs Affecting Lipid Metabolism
Surface Logix, Inc. announced the presentation of positive safety and efficacy data from its innovative Phase 1 repeat-dose clinical trial of its investigational drug candidate SLx-4090, a first-in-class enterocyte-specific microsomal triglyceride transfer protein (MTP) inhibitor being developed for the treatment of dyslipidemia (abnormal levels of lipids in the bloodstream).
Florida To Begin Newborn Screening For Cystic Fibrosis
The state of Florida will begin screening all newborns for cystic fibrosis (CF) starting July 1. Florida joins 36 other states in the country, plus the District of Columbia, to routinely screen for CF at birth. "This is the right thing to do," said Peter Hodge, a Boca Raton, Fla. father of two daughters with CF. Hodge's 14-year-old daughter, Olivia, wasn't diagnosed with the disease until she was a teenager. "We wish our daughter had been diagnosed at birth.
Cleft Palate In Fetal Mice Can Be Prevented
Mice engineered to have cleft palates can be rescued in utero by injecting the mothers with a small molecule to correct the defect, say scientists at the Stanford University School of Medicine and Lucile Packard Children's Hospital. In addition to shedding light on the biology of cleft palate, the research raises hopes that it may one day be possible to prevent many types of human birth defects by using a similar vaccination-type technique in pregnant women likely to have affected fetuses.